About this trial
Periodontitis is a widely prevalent disease worldwide that has serious public health consequences. Its prognosis includes tooth loss and edentulism, a condition that negatively affects chewing causing functional disability; and esthetics causing social impairment. Consequently, periodontitis may end up causing marked impairment of the quality of life of the affected patients, impairment of general health and increasing the dental care costs significantly.
Changes in the oral mucosa arise by primary products resulting from tissue breakdown due to gingivitis. It then triggers the host cells to produce proteinases that mediate loss of marginal periodontal ligaments, apical migration of the junctional epithelium and apical spread of bacterial biofilm.
Therefore, this research aims to identify the risk of smoking to both periodontitis and oral cancer, and the risk of periodontitis to oral cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients 18 years or older.
Disqualifiers
Patients with any systemic diseases.
Pregnant females.
Handicapped and mentally retarded patients.
Patients undergoing radiotherapy.
Trial population
Adult individuals
Trial design
Cohort
Prospective
Treatments tested in this trial
biopsy for oral cancer
Diagnostic testsurgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions
periodontal examination
Diagnostic testPeriodontal clinical examination to all by periodontal charting
Treatment groups
Trial outcomes
Primary outcomes
Periodontitis
arising of periodontitis or increase in the grade of an already existing case of periodontitis
Secondary outcomes
Oral cancer
Arising of a lesion of oral cancer or a premalignant lesion
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: